Qingmiao Lu

884 total citations
15 papers, 682 citations indexed

About

Qingmiao Lu is a scholar working on Nephrology, Molecular Biology and Immunology. According to data from OpenAlex, Qingmiao Lu has authored 15 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 7 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Qingmiao Lu's work include Chronic Kidney Disease and Diabetes (5 papers), Renal Diseases and Glomerulopathies (5 papers) and Epigenetics and DNA Methylation (2 papers). Qingmiao Lu is often cited by papers focused on Chronic Kidney Disease and Diabetes (5 papers), Renal Diseases and Glomerulopathies (5 papers) and Epigenetics and DNA Methylation (2 papers). Qingmiao Lu collaborates with scholars based in China and United States. Qingmiao Lu's co-authors include Chunsun Dai, Yuan Gui, Weichun He, Xian Xue, Junwei Yang, Xiaoli Sun, Bingyan Shu, Yan Liang, Feng Ye and Mengru Gu and has published in prestigious journals such as Journal of Biological Chemistry, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Qingmiao Lu

15 papers receiving 681 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingmiao Lu China 11 319 187 170 90 77 15 682
Xian Xue China 11 304 1.0× 183 1.0× 154 0.9× 58 0.6× 112 1.5× 16 649
Panagiotis Kavvadas France 19 441 1.4× 106 0.6× 225 1.3× 61 0.7× 104 1.4× 33 840
Marjolein Garsen Netherlands 10 313 1.0× 201 1.1× 210 1.2× 253 2.8× 86 1.1× 11 829
Bingyan Shu China 7 199 0.6× 150 0.8× 101 0.6× 25 0.3× 54 0.7× 7 489
Brigitte Langer Austria 11 304 1.0× 166 0.9× 245 1.4× 60 0.7× 65 0.8× 20 906
Isak W. Tengesdal United States 12 422 1.3× 303 1.6× 155 0.9× 31 0.3× 35 0.5× 15 732
Bryce G. Johnson United States 12 579 1.8× 144 0.8× 265 1.6× 48 0.5× 167 2.2× 15 1.1k
Purvi Mehrotra United States 17 195 0.6× 247 1.3× 158 0.9× 14 0.2× 68 0.9× 21 734
Fengqi Duan China 8 564 1.8× 120 0.6× 77 0.5× 23 0.3× 57 0.7× 11 756

Countries citing papers authored by Qingmiao Lu

Since Specialization
Citations

This map shows the geographic impact of Qingmiao Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingmiao Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingmiao Lu more than expected).

Fields of papers citing papers by Qingmiao Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingmiao Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingmiao Lu. The network helps show where Qingmiao Lu may publish in the future.

Co-authorship network of co-authors of Qingmiao Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Qingmiao Lu. A scholar is included among the top collaborators of Qingmiao Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingmiao Lu. Qingmiao Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Lu, Qingmiao, et al.. (2024). Rheb1 deficiency elicits mitochondrial dysfunction and accelerates podocyte senescence through promoting Atp5f1c acetylation. Cellular Signalling. 124. 111451–111451. 4 indexed citations
2.
Chen, Lijuan, Zhicheng Cui, Si-Jing Wang, et al.. (2023). Fecal microbiota transplantation ameliorates type 2 diabetes via metabolic remodeling of the gut microbiota in db/db mice. BMJ Open Diabetes Research & Care. 11(3). e003282–e003282. 29 indexed citations
3.
Gu, Mengru, Lu Zhou, Xiaoli Sun, et al.. (2022). Protein phosphatase 2Acα modulates fatty acid oxidation and glycolysis to determine tubular cell fate and kidney injury. Kidney International. 102(2). 321–336. 29 indexed citations
4.
Sun, Xiaoli, Qingmiao Lu, Yan Liang, et al.. (2022). Mechanistic target of rapamycin complex 1 orchestrates the interplay between hepatocytes and Kupffer cells to determine the outcome of immune-mediated hepatitis. Cell Death and Disease. 13(12). 1031–1031. 4 indexed citations
5.
Liang, Yan, Xiaoli Sun, Mingjie Wang, et al.. (2021). PP2Acα promotes macrophage accumulation and activation to exacerbate tubular cell death and kidney fibrosis through activating Rap1 and TNFα production. Cell Death and Differentiation. 28(9). 2728–2744. 21 indexed citations
6.
Lu, Qingmiao, et al.. (2021). PP2A Catalytic Subunit α promotes fibroblast activation and kidney fibrosis via ERK pathway. Cellular Signalling. 90. 110187–110187. 7 indexed citations
7.
Lu, Qingmiao, Qing Hou, Xiaoli Sun, et al.. (2021). Complement factor B in high glucose–induced podocyte injury and diabetic kidney disease. JCI Insight. 6(19). 21 indexed citations
8.
Lu, Qingmiao, Mingjie Wang, Yuan Gui, et al.. (2020). Rheb1 protects against cisplatin-induced tubular cell death and acute kidney injury via maintaining mitochondrial homeostasis. Cell Death and Disease. 11(5). 364–364. 51 indexed citations
9.
Gui, Yuan, Qing Hou, Qingmiao Lu, Chunsun Dai, & Jianzhong Li. (2020). Loss of Rictor in tubular cells exaggerates lipopolysaccharide induced renal inflammation and acute kidney injury via Yap/Taz-NF-κB axis. Cell Death Discovery. 6(1). 40–40. 7 indexed citations
10.
Gui, Yuan, Qingmiao Lu, Mengru Gu, et al.. (2019). Fibroblast mTOR/PPARγ/HGF axis protects against tubular cell death and acute kidney injury. Cell Death and Differentiation. 26(12). 2774–2789. 36 indexed citations
11.
Ye, Feng, Yan Liang, Mingjie Wang, et al.. (2018). The signaling protein Wnt5a promotes TGFβ1-mediated macrophage polarization and kidney fibrosis by inducing the transcriptional regulators Yap/Taz. Journal of Biological Chemistry. 293(50). 19290–19302. 108 indexed citations
12.
Gui, Yuan, Jianzhong Li, Qingmiao Lu, et al.. (2018). Yap/Taz mediates mTORC2-stimulated fibroblast activation and kidney fibrosis. Journal of Biological Chemistry. 293(42). 16364–16375. 57 indexed citations
13.
Xue, Xian, Jiafa Ren, Xiaoli Sun, et al.. (2018). Protein kinase Cα drives fibroblast activation and kidney fibrosis by stimulating autophagic flux. Journal of Biological Chemistry. 293(28). 11119–11130. 31 indexed citations
14.
Shu, Bingyan, Feng Ye, Yuan Gui, et al.. (2017). Blockade of CD38 diminishes lipopolysaccharide-induced macrophage classical activation and acute kidney injury involving NF-κB signaling suppression. Cellular Signalling. 42. 249–258. 74 indexed citations
15.
Ye, Feng, Jiafa Ren, Yuan Gui, et al.. (2017). Wnt/β-Catenin–Promoted Macrophage Alternative Activation Contributes to Kidney Fibrosis. Journal of the American Society of Nephrology. 29(1). 182–193. 203 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026